STOCK TITAN

Cyclacel Pharmaceuticals 6% Cnvrtbl. Prfrd. Stock (CYCCP) Debt by Year

CYCCP

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock held $3.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $3.5M
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CYCCP Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$3.5M+11.7%$3.1M-7.1%$3.4M-81.6%$18.3M-49.8%$36.6M+9.4%$33.4M+181.1%$11.9M-32.1%$17.5M-26.8%$23.9M+44.7%$16.5M-19.2%$20.4M-15.5%$24.2M-22.3%$31.1M+89.8%$16.4M-32.9%$24.4M

CYCCP Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$3.3M-3.2%$3.5M+11.7%$3.8M+28.7%$4.3M-28.7%$3.5M+23.3%$3.1M-7.1%$3.0M-49.8%$6.0M-41.0%$2.8M-75.5%$3.4M-81.6%$5.9M-74.9%$10.2M-65.0%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock financials

Frequently Asked Questions

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock held $3.5M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) reported on that line in every period on record.